Form 6-K Ascendis Pharma A/S For: Jun 30
http://archive.fast-edgar.com/20260813/AV2X822CC22242N2222Q22O2LC99Z2228282
Filed on: August 13, 2026
Form 144 SILICOM LTD. Filed by: Eizenman Liron
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 424B3 1st FRANKLIN FINANCIAL
Filed Pursuant to Rule 424(b)(3)SEC File #333-295692 1st FRANKLIN FINANCIAL CORPORATIONSENIOR DEMAND NOTESPERIODS OF AUGUST 13, 2026 THRU AUGUST 19, 2026ANDAUGUST 20, 2026 THRU AUGUST 26, 2026August 13, 2026 THRU August 19, 2026Daily Balance$1 to$2,499$2,500 to $9,999$10,000 to $49,999$50,000 to $99,999$100,000 & overEffective... (continue reading...)
Form 13F-HR GAM Holding AG For: Mar 31
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 6-K Kanzhun Ltd For: Aug 13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-40460
KANZHUN LIMITED
21/F, GrandyVic Building,
Taiyanggong Middle Road
Chaoyang District, Beijing 100028
People’s Republic of China
(Address of principal executive... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form SCHEDULE 13G THOR INDUSTRIES INC Filed by: Life Cycle Investment Partners Ltd
-
Form 13F-HR Dalal Street, LLC For: Jun 30
-
Form 13F-HR L1 Capital Pty Ltd For: Jun 30
-
Form 497J Tidal Trust II
-
Form D WEBULL EX INC
-
Form 8-K IREN Ltd For: Aug 13
-
Form 13F-HR L1 Capital International For: Jun 30
-
Form 13F-HR Evolutionary Tree Capita For: Jun 30
-
Form 10-Q Pyxis Oncology, Inc. For: Jun 30
-
Form 8-K Pyxis Oncology, Inc. For: Aug 13
-
Form 10-Q Karyopharm Therapeutics For: Jun 30
-
Form 8-K MiNK Therapeutics, Inc. For: Aug 13
-
Form 8-K Madison Square Garden For: Aug 13
-
Form 8-K CREATIVE REALITIES, INC. For: Aug 13
-
Form 6-K Arcos Dorados Holdings For: Aug 13
-
Form 13F-HR CDAM (UK) Ltd For: Jun 30
-
Form N-CEN Putnam ETF Trust For: May 31
-
Form 8-K Karyopharm Therapeutics For: Aug 13
-
Form 8-K Sprinklr, Inc. For: Aug 10
-
Form 4 EuroDry Ltd. For: Aug 12 Filed by: Pariaros Symeon
-
Form N-CEN Franklin Alternative For: May 31
-
Form 8-K Intuitive Machines, Inc. For: Aug 13
-
Form 10-Q Indaptus Therapeutics, For: Jun 30
-
Form 8-K Advanced Flower Capital For: Aug 13
-
Form 10-Q Cabaletta Bio, Inc. For: Jun 30
-
Form 424B3 Spire Global, Inc.
-
Form SCHEDULE 13G Mountain Crest Acquisiti Filed by: MIZUHO FINANCIAL GROUP INC
-
Form 8-K CorMedix Inc. For: Aug 13
-
Form 8-K Cabaletta Bio, Inc. For: Aug 13
-
Form 6-K Arcos Dorados Holdings For: Jun 30
-
Form 13F-HR PLATINUM INVESTMENT MANA For: Jun 30
-
Form N-PX JACKSON HILL ADVISORS, For: Jun 30
-
Form 144 CAMTEK LTD Filed by: Geva-Dvash Orit
-
Form 6-K NERVGEN PHARMA CORP. For: Aug 13
-
Form 13F-HR Virtu Financial LLC For: Jun 30
-
Form 10-Q Advanced Flower Capital For: Jun 30
-
Form 10-Q Falcon's Beyond Global, For: Jun 30
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 10-Q FITLIFE BRANDS, INC. For: Jun 30
-
Form 10-Q Grace Therapeutics, Inc. For: Jun 30
-
Form 8-K Beacon Financial Corp For: Aug 13
-
Form 10-Q ABEONA THERAPEUTICS INC. For: Jun 30
-
Form 8-K Yesway, Inc. For: Aug 13
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Aug 12
-
Form 8-K Falcon's Beyond Global, For: Aug 13
-
Form 8-K Indaptus Therapeutics, For: Aug 10
-
Form 8-K ABEONA THERAPEUTICS INC. For: Aug 13
-
Form 8-K WABASH NATIONAL Corp For: Aug 12
-
Form 10-Q Cocrystal Pharma, Inc. For: Jun 30
